StockDuty ← Dashboard Aug 28, 2026 05:01 AM ET
SignalKorea

SAMSUNG BIOLOGICS TO RAISE W3TR IN RIGHTS ISSUE FOR PEPTIDE MAKER DEAL - KOREAHERALD

Rights issue raises W3tr, funding peptide maker acquisition, signaling major capital deployment.

What changed
Why it matters
Rights issue raises W3tr, funding peptide maker acquisition, signaling major capital deployment.
Sources
koreaherald
Related signals
SK HYNIX HOLDS GROUNDBREAKING CEREMONY FOR HBM PRODUCTION BASE IN US - KOREAHERALD →MEET SK HYNIX, THE TRILLION-DOLLAR SOUTH KOREAN CHIPMAKER DEBUTING ON U.S. MARKETS - CNBC →SOUTH KOREA TO HOLD EMERGENCY MARKET MEETING AFTER KOSPI TURMOIL - BLOOMBERG - GNEWS →